| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AIDS recombinant vaccine; recombinant HIV virus core protein cloning in vaccinia virus vector
|
|
|
1991
|
9 |
1 |
p. 67-68
2 p.
|
artikel
|
| 2 |
Antigens of Cysticercus cellulosae; used for antibody production, treatment of neurocysticercosis, diagnosis or vaccine production
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 3 |
Calendar
|
|
|
1991
|
9 |
1 |
p. 72-
1 p.
|
artikel
|
| 4 |
Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus.
|
|
|
1991
|
9 |
1 |
p. 70-
1 p.
|
artikel
|
| 5 |
Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes
|
Verma, Naresh K.
|
|
1991
|
9 |
1 |
p. 6-9
4 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
1991
|
9 |
1 |
p. IFC-
1 p.
|
artikel
|
| 7 |
Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses
|
Resti, M.
|
|
1991
|
9 |
1 |
p. 15-18
4 p.
|
artikel
|
| 8 |
Fowl Mycoplasma antigen, vector and recombinant vaccine; Mycoplasma gallisepticum gene cloning and expression; fusion protein construction
|
|
|
1991
|
9 |
1 |
p. 67-
1 p.
|
artikel
|
| 9 |
Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep
|
Morrill, J.C.
|
|
1991
|
9 |
1 |
p. 35-41
7 p.
|
artikel
|
| 10 |
Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization
|
Klockmann, U.
|
|
1991
|
9 |
1 |
p. 42-46
5 p.
|
artikel
|
| 11 |
Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine
|
Øvernes, G.
|
|
1991
|
9 |
1 |
p. 25-28
4 p.
|
artikel
|
| 12 |
Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins
|
Lifely, M.Robert
|
|
1991
|
9 |
1 |
p. 60-66
7 p.
|
artikel
|
| 13 |
Immunogenicity of two f0ormulations of oral cholera vaccines in Thai volunteers
|
Chongsa-nguan, Manas
|
|
1991
|
9 |
1 |
p. 53-59
7 p.
|
artikel
|
| 14 |
Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines
|
Mulcahy, G.
|
|
1991
|
9 |
1 |
p. 19-24
6 p.
|
artikel
|
| 15 |
New avirulent Salmonella, containing DNA for Escherichia coli lipopolysaccharide core region, providing efficient expression of heterologous protein, especially cholera O-antigen; application as vaccine
|
|
|
1991
|
9 |
1 |
p. 67-
1 p.
|
artikel
|
| 16 |
Novel strain of influenza virus is useful in inactivated vaccine production
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 17 |
Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium
|
Jones, P.W.
|
|
1991
|
9 |
1 |
p. 29-34
6 p.
|
artikel
|
| 18 |
Polypeptide derived from Plasmodium falciparum antigen GLURP; vector plasmid pRD15 expression in Escherichia coli or Bacillus subtilis; recombinant vaccine construction and malaria therapy; monoclonal antibody and hybridoma preparation
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 19 |
Protein homologous to Trypanosoma cruzi heat shock protein; used in vaccine and diagnosis of e.g. Mycoplasma or Mycobacterium
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 20 |
Pseudomonas aeruginosa-derived elastase encoding DNA; potential application in recombinant vaccine production
|
|
|
1991
|
9 |
1 |
p. 67-
1 p.
|
artikel
|
| 21 |
Recombinant adenovirus for oral vaccine; containing a gene coding for an antigen, especially HBsAg, to produce antibody or induce cell-mediated immunity
|
|
|
1991
|
9 |
1 |
p. 67-
1 p.
|
artikel
|
| 22 |
Recombinant DNA encoding hepatitis B virus polypeptide antigen is used in detection of infection and in vaccine production; production in prokaryotic or eukaryotic host; core antigen, surface antigen DNA sequence
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 23 |
Recombinant vaccine against horse influenza virus; produced using DNA sequence encoding haemagglutinin and neuraminidase glycoproteins
|
|
|
1991
|
9 |
1 |
p. 67-
1 p.
|
artikel
|
| 24 |
Recombinant vaccines for poultry
|
Tomley, F.M.Fiona
|
|
1991
|
9 |
1 |
p. 4-5
2 p.
|
artikel
|
| 25 |
Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w
|
Singh, Indira G.
|
|
1991
|
9 |
1 |
p. 10-14
5 p.
|
artikel
|
| 26 |
Spread of ‘unconventional viruses’ through sheep-brain rabies vaccines
|
Arya, S.C.
|
|
1991
|
9 |
1 |
p. 70-
1 p.
|
artikel
|
| 27 |
Statistical analysis of virus titres obtained in repeated assays of working standard of trivalent oral polio vaccine
|
Sokhey, Jaspal
|
|
1991
|
9 |
1 |
p. 69-70
2 p.
|
artikel
|
| 28 |
Studies on the immunogenicity of chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB)
|
Page, M.
|
|
1991
|
9 |
1 |
p. 47-52
6 p.
|
artikel
|
| 29 |
Transgenic plant expressing antigen of pathogenic organism; e.g. using Escherichia coli or Streptococcus mutans, used for oral immunization to inhibit colonization or invasion by pathogens
|
|
|
1991
|
9 |
1 |
p. 68-
1 p.
|
artikel
|
| 30 |
'Vaccine' goes monthly
|
Spier, R.E.
|
|
1991
|
9 |
1 |
p. 3-
1 p.
|
artikel
|
Tijdschrift beschrijving